Association of oxidative stress and memory performance in postmenopausal women receiving estrogen-progestin therapy

被引:0
|
作者
Shafin, Nazlahshaniza [1 ]
Zakaria, Rahimah [1 ]
Hussain, Nik Hazlina Nik [2 ]
Othman, Zahiruddin [3 ]
机构
[1] Univ Sains Malaysia, Dept Physiol, Kubang Kerian 16150, Kelantan, Malaysia
[2] Univ Sains Malaysia, Womens Hlth Dev Unit, Kubang Kerian 16150, Kelantan, Malaysia
[3] Univ Sains Malaysia, Dept Psychiat, Sch Med Sci, Kubang Kerian 16150, Kelantan, Malaysia
关键词
Estrogen-progestin therapy; Postmenopause; Oxidative stress; Malay Version of Auditory Verbal Learning Test; HORMONE REPLACEMENT THERAPY; SURGICALLY MENOPAUSAL WOMEN; MILD COGNITIVE IMPAIRMENT; EARLY ALZHEIMERS-DISEASE; CEREBRAL-BLOOD-FLOW; LIPID-PEROXIDATION; NEURODEGENERATIVE DISORDERS; ANTIOXIDANT STATUS; APOLIPOPROTEIN-E; CONTROLLED-TRIAL;
D O I
10.1097/gme.0b013e31827758c6
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: The aim of this study was to examine the association between changes in blood oxidative stress level/activity and changes in memory performance among postmenopausal women. Methods: This study involved 39 postmenopausal women who received estrogen-progestin therapy (EPT) for 16 weeks. Verbal learning and memory performance were assessed using the Malay Version of Auditory Verbal Learning Test before and after 16 weeks of EPT. Oxidative stress levels/activities before and after 16 weeks of EPT were determined using commercially available kits. Data were analyzed using paired t test and r. P < 0.05 was considered significant. Results: The activities of glutathione peroxidase and catalase were considerably increased (P < 0.05), but the level of 4-hydroxynonenal was notably decreased (P < 0.05), after 16 weeks of EPT. There were positive correlations between changes in plasma superoxide dismutase and changes in trial A2 scores (r = 0.36, P < 0.05), and between changes in the ratio of blood reduced glutathione to oxidized glutathione and changes in trial A2 scores (r = 0.34, P < 0.05). Conclusions: Sixteen weeks of EPT increase blood antioxidant capacity. However, most of the changes in oxidative stress level/activity are not significantly associated with changes in the memory performance of postmenopausal women.
引用
收藏
页码:661 / 666
页数:6
相关论文
共 50 条
  • [21] Differing effects of low-dose estrogen-progestin therapy and pravastatin in postmenopausal hypercholesterolemic women
    Davis, SR
    Goldstat, R
    Newman, A
    Berry, K
    Burger, HG
    Meredith, I
    Koch, K
    CLIMACTERIC, 2002, 5 (04) : 341 - 350
  • [22] PROGESTIN ENHANCES VASOCONSTRICTOR RESPONSES IN POSTMENOPAUSAL WOMEN RECEIVING ESTROGEN REPLACEMENT THERAPY
    SULLIVAN, JM
    SHALA, BA
    MILLER, LA
    LERNER, JL
    MCBRAYER, JD
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 1995, 2 (04): : 193 - 199
  • [23] Progestin enhances vasoconstrictor responses in postmenopausal women receiving estrogen replacement therapy
    Sullivan, Jay M.
    Shala, Bashar A.
    Miller, Leslie A.
    Lerner, Jody L.
    McBrayer, John D.
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2018, 25 (11): : 1180 - 1186
  • [24] Transition from estrogen-progestin to raloxifene in postmenopausal women: Effect on vasomotor symptoms
    Gordon, S
    Walsh, BW
    Ciaccia, AV
    Siddhanti, S
    Rosen, AS
    Plouffe, L
    OBSTETRICS AND GYNECOLOGY, 2004, 103 (02): : 267 - 273
  • [25] Effects of estrogen-progestin therapy on serum levels of RANKL, osteoprotegerin, osteocalcin, leptin, and ghrelin in postmenopausal women
    Di Carlo, Costantino
    Tommaselli, Giovanni A.
    Gargano, Virginia
    Sammartino, Annalidia
    Bifulco, Giuseppe
    Tauchmanova, Libuse
    Colao, Annamaria
    Nappi, Carmine
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2007, 14 (01): : 38 - 44
  • [26] Estrogen-progestin use and breast cancer characteristics in lean and overweight postmenopausal women
    Kjartansdottir, Olof J.
    Sigurdardottir, Lara G.
    Olafsdottir, Elinborg J.
    Jonasson, Jon G.
    Ursin, Giske
    Tryggvadottir, Laufey
    BREAST CANCER RESEARCH AND TREATMENT, 2017, 163 (02) : 363 - 373
  • [27] Breast cancer incidence in women exposed to estrogen and estrogen-progestin replacement therapy
    Persson, I
    HORMONAL CARCINOGENESIS II, 1996, : 91 - 98
  • [28] Effects of continuous estrogen and estrogen-progestin replacement regimens on cardiovascular risk markers in postmenopausal women
    Davidson, MH
    Maki, KC
    Marx, P
    Maki, AC
    Cyrowski, MS
    Nanavati, N
    Arce, JC
    ARCHIVES OF INTERNAL MEDICINE, 2000, 160 (21) : 3315 - 3325
  • [29] SPIRONOLACTONE AND ESTROGEN-PROGESTIN THERAPY FOR HIRSUTISM
    BOARD, JA
    ROSENBERG, SM
    SMELTZER, JS
    SOUTHERN MEDICAL JOURNAL, 1987, 80 (04) : 483 - 486
  • [30] Aromatase Inhibitors and Mammographic Breast Density in Postmenopausal Women Receiving Estrogen Progestin Therapy
    Mousa, Noha A.
    Crystal, Pavel
    Wolfman, Wendy L.
    Bedaiwy, Mohamed A.
    Casper, Robert R.
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2008, 15 (06): : 1219 - 1220